Europe, Middle East & Africa Regional Advisory Council
Chair
Virginia Acha
Virginia (Ginny) has worked in industry and academia throughout her career, combining interests in science policy research and innovation performance within and across organizations. She joined MSD in 2017 to lead regulatory policy efforts ex-US for innovation that leads to better treatment for patients globally. Since 2020 this scope has expanded, as Ginny now leads the talented and experienced Global Regulatory Policy and Intelligence team for MSD. Her work has regularly focused on policy shocks that challenge innovation and access to novel therapies for patients, including global and industry-wide policy work on BREXIT, COVID-19 and now the R&D impacts of the Inflation Reduction Act.
Members
-
Fiona Adshead
Chair of the Sustainable Healthcare Coalition, Sustainable Healthcare Coalition
-
Angel Alberich-Bayarri
CEO, Quibim
-
Ursula Busse
CMC Regulatory Affairs Advisor, Self employed
-
Sinead Callinan
Head of Patient Centered Delivery, IQVIA
-
Maria Dutarte
Executive Director, European Patients Academy (EUPATI)
-
Sabine Haubenreisser
Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency
-
Jesper Kjær
Director of DKMA Data Analytics Centre, Danish Medicines Agency DKMA
-
Stephanie Millican
Deputy Director Benefit Risk Evaluation, Safety and Surveillance, MHRA
-
Yannis Natsis
European Social Insurance Platform (ESIP)
-
Elena Petelos
HTAI, University of Crete, School of Medicine, HTAi
-
Elena Popa
Chief of Staff, Global Regulatory Affairs, Bayer
-
Marco Rafael
Regulatory Policy Leader, Roche
-
Gabriela Zenhaeusern
Deputy Head Stakeholder Engagement, Swissmedic